79 related articles for article (PubMed ID: 21270424)
21. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
Kannisto K; Chibalin A; Glinghammar B; Zierath JR; Hamsten A; Ehrenborg E
Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
[TBL] [Abstract][Full Text] [Related]
23. NPY
Wittrisch S; Klöting N; Mörl K; Chakaroun R; Blüher M; Beck-Sickinger AG
Mol Metab; 2020 Jan; 31():163-180. PubMed ID: 31918918
[TBL] [Abstract][Full Text] [Related]
24. Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARalpha/gamma agonist, tesaglitazar.
Fagerberg B; Schuster H; Birketvedt GS; Tonstad S; Ohman KP; Gause-Nilsson I;
Diab Vasc Dis Res; 2007 Sep; 4(3):174-80. PubMed ID: 17907107
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor-alpha,gamma-agonist improves insulin sensitivity and prevents loss of left ventricular function in obese dyslipidemic mice.
Verreth W; Ganame J; Mertens A; Bernar H; Herregods MC; Holvoet P
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):922-8. PubMed ID: 16456093
[TBL] [Abstract][Full Text] [Related]
27. Effects of PPARgamma and PPARalpha agonists on serum leptin levels in diet-induced obese rats.
Törüner F; Akbay E; Cakir N; Sancak B; Elbeg S; Taneri F; Aktürk M; Karakoç A; Ayvaz G; Arslan M
Horm Metab Res; 2004 Apr; 36(4):226-30. PubMed ID: 15114521
[TBL] [Abstract][Full Text] [Related]
28. [Effect of peroxisome proliferator-activated receptor-alpha agonist on adipokines expression in rats fed with high-fat diet].
Li Y; Huang B; Cheng H; Liang Z; Liu SY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):761-5. PubMed ID: 17260462
[TBL] [Abstract][Full Text] [Related]
29. The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice.
van der Hoorn JW; Jukema JW; Havekes LM; Lundholm E; Camejo G; Rensen PC; Princen HM
Br J Pharmacol; 2009 Apr; 156(7):1067-75. PubMed ID: 19220285
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat.
Ovcharenko E; Hansen MK; Goltsman I; Abu-Saleh N; Abassi Z; Walsh K; Miele G; Feuerstein GZ; Winaver J
Nephron Physiol; 2010; 115(3):p21-30. PubMed ID: 20460939
[TBL] [Abstract][Full Text] [Related]
31. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
32. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
Chen N; Bezzina R; Hinch E; Lewandowski PA; Cameron-Smith D; Mathai ML; Jois M; Sinclair AJ; Begg DP; Wark JD; Weisinger HS; Weisinger RS
Nutr Res; 2009 Nov; 29(11):784-93. PubMed ID: 19932867
[TBL] [Abstract][Full Text] [Related]
33. Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
Guo Y; Jolly RA; Halstead BW; Baker TK; Stutz JP; Huffman M; Calley JN; West A; Gao H; Searfoss GH; Li S; Irizarry AR; Qian HR; Stevens JL; Ryan TP
Toxicol Sci; 2007 Apr; 96(2):294-309. PubMed ID: 17255113
[TBL] [Abstract][Full Text] [Related]
34. PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.
Blednov YA; Black M; Benavidez JM; Stamatakis EE; Harris RA
Alcohol Clin Exp Res; 2016 Mar; 40(3):553-62. PubMed ID: 26857685
[TBL] [Abstract][Full Text] [Related]
35. Resistance to excessive bodyweight gain in risperidone-injected rats.
Ota M; Mori K; Nakashima A; Kaneko YS; Takahashi H; Ota A
Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):279-87. PubMed ID: 15810992
[TBL] [Abstract][Full Text] [Related]
36. Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice.
Chira EC; McMillen TS; Wang S; Haw A; O'Brien KD; Wight TN; Chait A
Atherosclerosis; 2007 Nov; 195(1):100-9. PubMed ID: 17214992
[TBL] [Abstract][Full Text] [Related]
37. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
Laurent D; Gounarides JS; Gao J; Boettcher BR
Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
Han KL; Choi JS; Lee JY; Song J; Joe MK; Jung MH; Hwang JK
Diabetes; 2008 Mar; 57(3):737-45. PubMed ID: 18065517
[TBL] [Abstract][Full Text] [Related]
39. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
Hsu SC; Huang CJ
J Nutr Biochem; 2007 Feb; 18(2):86-96. PubMed ID: 16713235
[TBL] [Abstract][Full Text] [Related]
40. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin.
Oana F; Takeda H; Hayakawa K; Matsuzawa A; Akahane S; Isaji M; Akahane M
Metabolism; 2005 Aug; 54(8):995-1001. PubMed ID: 16092047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]